Value of genetic and genomic technologies
Adam C. Berger
Challenges and opportunities in using residual newborn screening samples for translational research
Integrating Large-Scale Genomic Informat
Integrating Large-Scale Genomic Information into Clinical Practice
Generating evidence for genomic diagnostic test development
Economics of Genomic Medicine
Conflict of Interest and Medical Innovat
Conflict of Interest and Medical Innovation : Ensuring Integrity While Facilitating Innovation in Medical Research
Improving the Efficiency and Effectivene
Improving the Efficiency and Effectiveness of Genomic Science Translation
Drug Repurposing and Repositioning
Improving Genetics Education in Graduate
Improving Genetics Education in Graduate and Continuing Health Professional Education
Assessing Genomic Sequencing Information
Assessing Genomic Sequencing Information for Health Care Decision Making
Genomics-Enabled Learning Health Care Systems : Gathering and Using Genomic Information to Improve Patient Care and Research
Refining processes for the co-development of genome-based therapeutics and companion diagnostic tests
Genome-Based Diagnostics : Clarifying Pa
Genome-Based Diagnostics : Clarifying Pathways to Clinical Use
Genome-Based Therapeutics : Targeted Dru
Genome-Based Therapeutics : Targeted Drug Discovery and Development
Genome-Based Diagnostics : Demonstrating
Genome-Based Diagnostics : Demonstrating Clinical Utility in Oncology
Establishing Precompetitive Collaboratio
Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development
Stem Cell Therapies
Melanoma, an Issue of Surgical Oncology
Melanoma, an Issue of Surgical Oncology Clinics of North America
Genome-Based Diagnostics
Genome-Based Therapeutics
